Results 101 to 110 of about 160 (125)
Some of the next articles are maybe not open access.

Chemische Pleurodese mittels Glucose 40% – 18 Jahre Erfahrung

Zentralblatt Fur Chirurgie, 2019
T Bohanes   +7 more
exaly   +2 more sources

Pleurodese maligner Ergüsse

Atemwegs- Und Lungenkrankheiten, 2006
exaly   +2 more sources

Pleurale Reaktionsmuster nach Talkum-Pleurodese

Der Pathologe, 1998
Aufgrund der auch in Deutschland zunehmenden Bedeutung von Talkumpleurodesen fur die Therapie von malignen und benignen Pleuraergussen wurden Praparate der Pleura nach Talkumpleurodesen vergleichend mit Befunden nach Tetracyclin- und Novantron®-Pleurodesen von 24 Patienten bis zu einem Zeitraum von maximal 18 Monaten nach intrapleuraler Therapie ...
M. Krismann, K. Pieper, K.-M. Müller
openaire   +1 more source

Comparing transforming growth factor beta‐2 and fibronectin as pleurodesing agents

Respirology, 2001
Background: We have recently demonstrated that transforming growth factor beta‐2 (TGF‐β2) can produce effective pleurodesis. Whether this effect can be reproduced by the use of its downstream proteins is not known. This study compared the effectiveness of TGF‐β2 and fibronectin in inducing pleurodesis in rabbits.Methodology: New Zealand white ...
Y C, Lee   +6 more
openaire   +2 more sources

Pleurodese durch getunnelten Pleurakatheter: Können wir den Erfolg vorhersagen?

Kompass Pneumologie, 2023
Background: A well-recognized therapy to improve the symptoms of patients with malignant pleural effusion (MPE), indwelling pleural catheters (IPCs) can also achieve spontaneous pleurodesis. Chemical pleurodesis is associated with a significant pro-coagulation and fibrinolytic environment.
openaire   +1 more source

Who Gains Most? A 10-Year Experience With 611 Thoracoscopic Talc Pleurodeses

The Annals of Thoracic Surgery, 2007
Thoracoscopic talc pleurodesis is a therapeutic option for recurrent pleural effusion.This retrospective study included 611 patients who underwent thoracoscopic talc pleurodesis between 1994 and 2003. We analyzed the risk factors, efficiency, outcome, follow-up, and survival, while taking into consideration primary disease and general condition.The ...
Volker, Steger   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy